TARA vs REGN: Which Stock is Better?
Side-by-side comparison of Protara Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026
TARA
Protara Therapeutics Inc
—
REGN
Regeneron Pharmaceuticals Inc
$662.88
Key Metrics Comparison
| Metric | TARA | REGN | Winner |
|---|---|---|---|
| Market Cap | $228.75M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze TARA
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TARA or REGN a better investment?
Comparing TARA and REGN: Protara Therapeutics Inc has a market cap of $228.75M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TARA and REGN?
TARA (Protara Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TARA or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: TARA or REGN?
Both TARA and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: TARA or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: TARA or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $228.75M for TARA.
Should I buy TARA or REGN in 2026?
Both TARA and REGN have investment merit. TARA trades at $N/A while REGN trades at $662.88. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TARA and REGN stock?
Key differences: Market Cap ($228.75M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy TARA or REGN in 2026?
The choice between TARA and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between TARA and REGN?
TARA (Protara Therapeutics Inc) has a market cap of $228.75M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.